相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand F-18-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls
Tobey J. Betthauser et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Discovery of N-(4-[18F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer
Frederik J. R. Rombouts et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span
Suzanne L. Baker et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules
Benjamin Falcon et al.
NATURE (2019)
Tau Positron-Emission Tomography in Former National Football League Players
Robert A. Stern et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease
Ron Brookmeyer et al.
ALZHEIMERS & DEMENTIA (2018)
FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis
Hugo Botha et al.
BRAIN (2018)
Evaluation of F-18-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain
Hiroto Kuwabara et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2
Gil Leurquin-Sterk et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer's Disease
Frederik J. R. Rombouts et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
Kok Pin Ng et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Revisiting the Logan plot to account for non-negligible blood volume in brain tissue
Martin Schain et al.
EJNMMI RESEARCH (2017)
Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2016)
Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease
Sergey Shcherbinin et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
Eric D. Hostetler et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future
Manuela Ariza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Suggested pathway to assess radiation safety of 18F-labeled PET tracers for first-in-human studies
Paolo Zanotti-Fregonara et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand F-18-AV-45 (Flobetapir F 18)
Dean F. Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Quantitative MR Imaging of Brain Iron: A Postmortem Validation Study
Christian Langkammer et al.
RADIOLOGY (2010)
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer:: proof of mechanism
Christopher C. Rowe et al.
LANCET NEUROLOGY (2008)
Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest
Ioannis S. Gousias et al.
NEUROIMAGE (2008)
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe
A Hammers et al.
HUMAN BRAIN MAPPING (2003)
分享论文
